The exogenous tumor antigens in cancer vaccines can be delivered to APCs, particularly dendritic cells (DCs), to induce CD4+ T-cell and cytotoxic T lymphocyte (CTL) responses, thereby eliminating tumor cells [10]. The gene discussed is CD4; the disease is neoplasm.